Palla Roberta

Category D - Technical, data processing and scientific-technical Area



Via Pace, 9 - Ospedale Maggiore Policlinico - Pad. Primo
20122 MILANO (MI)

Altro numero di telefono
University email address


  • An international registry of patients with plasminogen deficiency (HISTORY) / A.D. Shapiro, M. Menegatti, R. Palla, M. Boscarino, C. Roberson, P. Lanzi, J. Bowen, C. Nakar, I.A. Janson, F. Peyvandi. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 105:3(2020 Mar 01), pp. 554-561.
  • Hemostatic alterations in COVID-19 / F. Peyvandi, A. Artoni, C. Novembrino, S. Aliberti, M. Panigada, M. Boscarino, R. Gualtierotti, F. Rossi, R. Palla, I. Martinelli, G. Grasselli, F. Blasi, A. Tripodi. - In: HAEMATOLOGICA. - ISSN 0390-6078. - (2020). [Epub ahead of print]
  • Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP Registry / I. Mancini, S. Pontiggia, R. Palla, A. Artoni, C. Valsecchi, B. Ferrari, D. Mikovic, F. Payvandi. - In: THROMBOSIS AND HAEMOSTASIS. - ISSN 0340-6245. - 119:5(2019 May), pp. 695-704.
  • Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" / A. Messori, F. Peyvandi, S. Trippoli, R. Palla, F.R. Rosendaal, P.M. Mannucci. - In: BLOOD TRANSFUSION. - ISSN 1723-2007. - 17:1(2019 Feb), pp. 86-86.
  • Role of the factor VIII-binding capacity of endogenous von Willebrand factor on the development of factor VIII inhibitors in patients with severe hemophilia A / Y. Repessé, C. Costa, R. Palla, E. Farrokhi Moshai, A. Borel-Derlon, R. D'Oiron, C. Rothschild, A. El-Beshlawy, M. Elalfy, V. Ramanan, P. Eshghi, J. Oldenburg, A. Pavlova, F.R. Rosendaal, F. Peyvandi, S.V. Kaveri, S. Lacroix-Desmazes. - In: HAEMATOLOGICA. - ISSN 0390-6078. - (2019 Jan 31). [Epub ahead of print]